Biotech · Private company · San Diego, CA, US
Poseida Therapeutics, Inc.
SEC CIK 0001661460
Track this companyFree. Adds Poseida Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials64 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- P-BCMA-101 CAR-T cellsPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- RimiducidPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- MethotrexatePhase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- P-BCMA-ALLO1 CAR-T cellsPhase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- P-CD19CD20-ALLO1Phase 1 · Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedClinicalTrials.gov · fetched Nov 12, 2026
- P-MUC1C-ALLO1 CAR-T cellsPhase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- P-PSMA-101 CAR-T cellsPhase 1 · Prostatic Neoplasms, Castration-ResistantClinicalTrials.gov · fetched Nov 12, 2026
- RimiducidPhase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- RimiducidPhase 1 · Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedClinicalTrials.gov · fetched Nov 12, 2026
- RimiducidPhase 1 · Prostatic Neoplasms, Castration-ResistantClinicalTrials.gov · fetched Nov 12, 2026
- Rimiducid may be administered as indicatedPhase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell MalignanciesPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 16, 2024ClinicalTrials.gov NCT06014762 · fetched Nov 12, 2026
- P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple MyelomaPHASE1 · ACTIVE_NOT_RECRUITING · started May 5, 2022ClinicalTrials.gov NCT04960579 · fetched Nov 12, 2026
- P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Feb 15, 2022ClinicalTrials.gov NCT05239143 · fetched Nov 12, 2026
- P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)PHASE1 · TERMINATED · started Feb 28, 2020ClinicalTrials.gov NCT04249947 · fetched Nov 12, 2026
- Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101PHASE1 · ACTIVE_NOT_RECRUITING · started Oct 29, 2018ClinicalTrials.gov NCT03741127 · fetched Nov 12, 2026
- P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)PHASE1_PHASE2 · TERMINATED · started Sep 20, 2017ClinicalTrials.gov NCT03288493 · fetched Nov 12, 2026